News About: Goverment
Avandia to be withdrawn from market
GlaxoSmithKline’s blockbuster anti-diabetic agent Avandia (rosiglitazone) will be banned from sales in the Korean market due to its possible cardiovascular risks.
The Korea Food and Drug Administration said on Sept...
KFDA seeks to upgrade drug-related administration via GRP
The Korea Food and Drug Administration has recently revised 21 standard operating procedures (SOPs) of Good Review Practice (GRP) to ensure transparency in screening drug-related applications.
GRP is a “documented ...
Government to scrap new drug-pricing plan
The government plans to implement a new drug-pricing system aimed at uprooting rampant illegal rebate activities in the pharmaceutical industry.
Starting in October this year, the Ministry for Health, Welfare and ...
Government specifies illegal rebate activities in pharmaceutical sector
Starting this November, treating a doctor with a meal worth more than 100,000 won will be considered a rebate activity in the pharmaceutical industry.
The Ministry of Health and Welfare plans to enact a bill to leg...
Korea to tighten local controls on tar pigments
Korea will strengthen controls over local use of 10 tar pigments, including Red Pigment No. 40, which can be used in drugs, quasi-drugs and cosmetic products as a color agent, health authorities says.
In order to ...
KPMA to support scientific conferences
The Korea Pharmaceutical Manufacturers Association recently approved a variety of voluntary donation programs, under which pharmaceutical firms may be able to back local scientific conferences.
The association also...
Warning issued against possible drug interactions
The Korea Food and Drug Administration warned consumers against any possible adverse drug reaction associated with alcohol and drug-drug interactions, advising them to thoroughly check the labels during Chuseok, which...
Government to ameliorate DMF system
The Korea Food and Drug Administration plans to overhaul the drug master file (DMF) system for active pharmaceutical ingredients.
Under the plan, the drug agency will readjust the schedules of DMF related inspectio...
Government urged to delay unified distribution plan
The Korean government needs to consider deferring the controversial unified distribution system which is due to expire at the end of this year, according to Hwawoo, a local law and patent office.
In a statement del...
Government, multinationals spar over insurance prices of new drugs
The Korean government and some foreign drug manufacturers, including Pfizer Korea and MSD Korea and Abbott Korea, BMS Korea and GlaxoSmithKline, are walking a tightrope not to irritate each other, but their conflictin...
